SeaStar Medical

NASDAQ: ICU · Real-Time Price · USD
0.81
-0.07 (-7.95%)
At close: Aug 15, 2025, 3:59 PM
0.81
0.06%
After-hours: Aug 15, 2025, 07:57 PM EDT

SeaStar Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
766K 428K 135K 68K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
27K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
739K 428K 135K 68K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-14.8M -17.71M -17.84M -16.02M -14.5M -13.58M -14.21M -18.98M -17.82M -15.38M -11.61M -4.27M -3.65M -3.53M -3.78M -3.41M -2.26M -1.07M
Interest Income
170K 150K 102K 83K 25.22K 449.00 882.00 1.03K 805.00 580.00 147.00 147K 201K 201K 201K 54K n/a n/a
Pretax Income
-14.67M -15.9M -24.83M -30.29M -33.24M -33.67M -26.23M -35.57M -30.03M -27.27M -23.01M -5.01M -2.89M -3.09M -3.15M -1.94M -2.18M -1.07M
Net Income
-14.67M -15.9M -24.83M -30.29M -33.23M -33.67M -26.23M -42.32M -36.78M -34.02M -29.76M -3.68M -1.55M -1.76M -1.82M -1.94M -2.18M -1.07M
Selling & General & Admin
7M 8.3M 8.87M 8.74M 8.38M 7.79M 8.33M 10.75M 9.97M 8.94M 6.6M 2.59M 1.96M 1.9M 1.75M 1.38M 973.24K 321.24K
Research & Development
8.54M 9.84M 9.11M 7.54M 6.31M 5.99M 6.07M 6.04M 5.66M 4.25M 2.82M 2.18M 2.44M 2.38M 2.77M 2.27M 1.28M 746K
Other Expenses
n/a n/a n/a -193.8K -193.8K -193.8K -193.8K 2.19M 2.19M 2.19M 2.19M n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
15.54M 18.14M 17.98M 16.09M 14.5M 13.58M 14.21M 18.98M 17.82M 15.38M 11.61M 4.27M 2.91M 2.79M 3.04M 2.67M 2.26M 1.07M
Interest Expense
21K 112K 244K 696K 648K 791K 1.08M 1.03M 928K 894K 630K 483K 360K 178K 11K 11K 11K 2K
Selling & Marketing Expenses
n/a n/a n/a 32K 32K 32K 32K n/a n/a n/a n/a 8K 16K 16K 16K 8K n/a n/a
Cost & Expenses
15.57M 18.14M 17.98M 16.09M 14.5M 13.58M 14.21M 18.98M 17.82M 15.38M 11.61M 4.27M 2.91M 2.79M 3.04M 2.67M 2.26M 1.07M
Income Tax Expense
3K 6K 3K -2K -2K n/a n/a 152K 153K 148K 148K -1.04M -1.04M -1.03M -1.03M 12K 10K 1K
Shares Outstanding (Basic)
11.33B 8.62M 4.92M 4.09M 3.15M 2.68M 1.54M 801K 597K 521K 445K 289K 289K 289K 521.64K 521.64K 507.99K 521.64K
Shares Outstanding (Diluted)
11.33B 8.62M 4.92M 4.09M 3.15M 2.68M 1.54M 801.94K 597.32K 521.03K 445.15K 507.99K 289.55K 289.55K 521.64K 521.64K 507.99K 521.64K
EPS (Basic)
-2.62 -3.47 -7.76 -13.26 -21.18 -24.25 -33.02 -69.8 -62.92 -61.94 -50.42 -6.84 -3.55 -9.6 -16.45 -16.86 -18.01 -8.84
EPS (Diluted)
-2.62 -3.47 -7.76 -13.26 -21.18 -24.25 -33.02 -69.79 -64.49 -63.51 -51.99 -8.42 -3.55 -9.6 -16.45 -16.86 -18.01 -8.84
EBITDA
-14.39M -15.79M -24.58M -29.59M -32.39M -31.46M -23.49M -32.87M -26.14M -23.74M -19.99M -922.44K -652.44K -1.93M -2.16M -2.16M -2.16M -1.07M
EBIT
-12.38M -15.53M -24.33M -29.59M -32.39M -32.68M -26.79M -36.18M -30.94M -28.81M -22.96M -4.94M -4.32M -4.99M -5.24M -4.21M -3.05M -1.07M
Depreciation & Amortization
3.82M 5.34M 5.46M 5.72M 5.47M 7.7M 8.33M 4.44M 6.21M 3.77M n/a 4.94M 4.32M 3.01M 2.2M 1.16M n/a n/a